Celldex Therapeutics (CLDX) Long-Term Debt Issuances (2011 - 2013)

Celldex Therapeutics (CLDX) recorded quarterly Long-Term Debt Issuances of -$9.7 million in Q2 2013, down 633.64% quarter-over-quarter from -$1.3 million in Q1 2013.

Celldex Therapeutics (CLDX) Long-Term Debt Issuances (2011 - 2013) Analysis & Trends

Celldex Therapeutics' Long-Term Debt Issuances history runs 3 years deep, the most recent figure standing at -$9.7 million for Q2 2013.

  • In Q2 2013, Long-Term Debt Issuances changed N/A year-over-year to -$9.7 million; the TTM figure through Dec 2020 stood at -$11.0 million (changed N/A YoY), while the FY2020 annual figure was $3.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances was -$9.7 million for Q2 2013 at Celldex Therapeutics, down from -$1.3 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $5.0 million in Q1 2011 to a low of -$9.7 million in Q2 2013.
  • Historically, Long-Term Debt Issuances has averaged -$1.7 million across 3 years, with a median of -$1.3 million in 2012.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.73 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Celldex Therapeutics 2.16 Bn 2.16 Bn -1.44 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2013 -9.71 Mn
Jun 30, 2013 -9.71 Mn
Mar 31, 2013 -1.32 Mn
Mar 31, 2013 -1.32 Mn
Dec 31, 2012 -1.33 Mn
Dec 31, 2012 -1.33 Mn
Sep 30, 2012 -1.32 Mn
Sep 30, 2012 -1.32 Mn
Mar 31, 2011 5.00 Mn
Mar 31, 2011 5.00 Mn